Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma
Stephen M Ansell, John Radford, Joseph M Connors, Monika Długosz-Danecka, Won-Seog Kim, Andrea Gallamini, Radhakrishnan Ramchandren, Jonathan W Friedberg, Ranjana Advani, Andrew M Evens, Piotr Smolewski, Kerry J Savage, Nancy L Bartlett, Hyeon-Seok Eom, Jeremy S Abramson, Cassie Dong, Frank Campana, Keenan Fenton, Markus Puhlmann, David J StrausECHELON-1 Study Group, Martin Hutchings
Dyk ned i forskningsemnerne om 'Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma'. Sammen danner de et unikt fingeraftryk.